Elanco Animal Health (ELAN) Operating Expenses (2017 - 2026)
Elanco Animal Health (ELAN) posted Operating Expenses of $494.0 million for Q1 2026, down 21.96% sequentially from $633.0 million in Q4 2025, and up 11.26% YoY from $444.0 million in Q1 2025.
Elanco Animal Health (ELAN) Operating Expenses (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported Operating Expenses for 10 years, with the latest figure at $494.0 million in Q1 2026.
- Quarterly Operating Expenses rose 11.26% year-over-year to $494.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 billion (down 34.88% YoY) and the FY2025 annual result came in at $2.0 billion, down 48.49% from the prior year.
- Operating Expenses retreated to $494.0 million in Q1 2026 per ELAN's latest filing, from $633.0 million in the prior quarter.
- Over five years, Operating Expenses peaked at $2.2 billion in Q3 2023 and troughed at $444.0 million in Q1 2025.
- A 5-year average of $975.1 million and a median of $1.1 billion in 2022 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses jumped 102.34% in 2023, then sank 78.24% in 2024.
- Over 5 years, Operating Expenses stood at $1.1 billion in 2022, then gained by 8.19% to $1.2 billion in 2023, then declined by 7.83% to $1.1 billion in 2024, then tumbled by 40.9% to $633.0 million in 2025, then dropped by 21.96% to $494.0 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $494.0 million, $633.0 million, and $465.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | 477.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 550.00 Mn |
| Mar 31, 2026 | 494.00 Mn |
| Dec 31, 2025 | 633.00 Mn |
| Sep 30, 2025 | 465.00 Mn |
| Jun 30, 2025 | 493.00 Mn |
| Mar 31, 2025 | 444.00 Mn |
| Dec 31, 2024 | 1.07 Bn |
| Sep 30, 2024 | 471.00 Mn |
| Jun 30, 2024 | 1.22 Bn |
| Mar 31, 2024 | 1.19 Bn |
| Dec 31, 2023 | 1.16 Bn |
| Sep 30, 2023 | 2.17 Bn |
| Jun 30, 2023 | 1.14 Bn |
| Mar 31, 2023 | 1.15 Bn |
| Dec 31, 2022 | 1.07 Bn |
| Sep 30, 2022 | 1.07 Bn |
| Jun 30, 2022 | 1.19 Bn |
| Mar 31, 2022 | 1.15 Bn |
| Dec 31, 2021 | 1.24 Bn |
| Sep 30, 2021 | 1.26 Bn |